Abstract: This invention relates to the 2-isopropylamino-pyrimidine-N-oxide of the formula: ##STR1## to a preparation process of the same consisting in submitting at 15.degree. to 45.degree. C., 2-isopropylamino pyrimidine to a smooth oxidation by stoichiometric proportions or a slight excess of up to 10% of an appropriate oxidizing agent and to a therapeutic composition of matter comprising said compound as an active ingredient therein.

Abstract: This invention relates to new 1,3-dihydro-6-methyl-7-hydroxy-furo-(3,4-c)-pyridine derivatives of the general formula ##STR1## wherein A< represents a group of the formula --(CH.sub.2).sub.n --, n being an integer of from 1 to 5, or a homocyclic or heterocyclic group, and R represents a hydrogen, chlorine or fluorine atom, a trifluoromethyl group, an alkyl group having from 1 to 5 carbon atoms, an alkoxy group having from 1 to 5 carbon atoms, a alkylthio group having from 1 to 5 carbon atoms, a dialkylaminoalkoxy group in which the alkyl groups each have from 1 to 5 carbon atoms and the alkoxy group has from 1 to 5 carbon atoms or a N-pyrolidinyl-alkoxy group in which the alkoxy group has from 1 to 5 carbon atoms to a process for the preparation of the same by refluxing .alpha..sup.

Abstract: This invention relates to a new phenoxy acetic acid derivative, to a method for its preparation and to therapeutic compositions containing it.

Abstract: The invention provides a process for the preparation of 2-isopropylamino-pyrimidine, the process comprising reacting bis(isopropylguanidine)sulphate with 1,1,3,3-tetraethoxy-propane in stoichiometric proportions at 40.degree.-60.degree. C., in acidic aqueous solution.

Abstract: The invention relates to new isopropylamino pyrimidine halogeno derivatives of the formula: ##STR1## in which X represents a fluorine, a chlorine or a bromine atom. These compounds, when X stands for chlorine or bromine, are prepared by reacting, at room temperature and in stoichiometric proportions, 2-isopropylamino pyrimidine on the appropriate N-halogeno succinimide, in the presence of acetic acid.

Abstract: A new phenoxy alkylamide is disclosed. The compound has been found to have beneficial activity in the field of immuno-stimulation.

Abstract: A therapeutic use for a phenoxy acetic acid is disclosed. The compound is effective as a choleretic agent and can be administered orally or intravenously.

Abstract: New phenothiazine derivatives having pharmaceutical activity are disclosed. The compounds are of particular interest because of their neuroleptic activity. The compounds are suitably prepared by reacting an N-substituted phenothiazine with an O,O'-isopropylidenyl-2-methyl-3-hydroxy-4-hydroxymethyl-5-(N-piperazinylme thyl)-pyridine.

Abstract: A method of treating hyperlipemia, hypertriglyceridemia and hypercholesterodemia is disclosed. The treatment comprises the administration in a pharmaceutically acceptable carrier of an effective amount of a p-halo-N-cyanoalkyl isobutyramide.

Abstract: A new vincamine salt of therapeutic interest is disclosed. The salt is vincamine pyridoxal 5-phosphate and exhibits surprisingly greater activity than vincamine alone. A process for the preparation of the compound is also disclosed.

Abstract: A process for the preparation of an isobutyramide is disclosed. A sodium phenolate is prepared by reacting sodium with a phenol in ethanol, an excess of toluene is added to the solution to form an ethanol/toluene azeotrope which azeotrope is then removed by distillation whereafter a N-cyanoalkyl .alpha.-bromo-isobutyramide is added, the mixture is refluxed for a period of 6-15 hours after which water is added to form a precipitate which is then removed from the reaction mixture.

Abstract: A new pharmaceutical compound having analgesic activity is disclosed. The compound is N-2, 6-dichloro-phenyl-2-aminopyrimidine. A method of preparing the compound is also disclosed as is a therapeutic composition which includes the compound.

Abstract: A therapeutic composition of matter presenting a favorable action in the field of nerve regeneration is disclosed. An effective amount of 2-isopropylamino pyrimidine orthophosphate is incorporated in an appropriate carrier. Also disclosed is a process of producing the orthophosphate of 2-isopropylamino pyrimidine.

Abstract: Dichloro acetate of 2-isopropyl amino pyrimidine is an active ingredient in drug for the treatment of neuropathies.